Credit Suisse’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,747
| Closed | -$93K | – | 3520 |
|
|
2019
Q1 | $93K | Buy |
2,747
+973
| +55% | +$32.9K | ﹤0.01% | 3261 |
|
|
2018
Q4 | $52K | Buy |
+1,774
| New | +$52K | ﹤0.01% | 3261 |
|
|
2018
Q3 | – | Sell |
-2,133
| Closed | -$158K | – | 3464 |
|
|
2018
Q2 | $158K | Buy |
2,133
+518
| +32% | +$38.4K | ﹤0.01% | 3329 |
|
|
2018
Q1 | $106K | Buy |
1,615
+240
| +17% | +$15.8K | ﹤0.01% | 3366 |
|
|
2017
Q4 | $116K | Sell |
1,375
-910
| -40% | -$76.8K | ﹤0.01% | 3322 |
|
|
2017
Q3 | $264K | Buy |
+2,285
| New | +$264K | ﹤0.01% | 3319 |
|
|
2017
Q2 | – | Sell |
-1,215
| Closed | -$150K | – | 3520 |
|
|
2017
Q1 | $150K | Sell |
1,215
-2,586
| -68% | -$319K | ﹤0.01% | 3284 |
|
|
2016
Q4 | $518K | Buy |
3,801
+1,085
| +40% | +$148K | ﹤0.01% | 3075 |
|
|
2016
Q3 | $540K | Sell |
2,716
-832
| -23% | -$165K | ﹤0.01% | 3050 |
|
|
2016
Q2 | $460K | Buy |
3,548
+428
| +14% | +$55.5K | ﹤0.01% | 3180 |
|
|
2016
Q1 | $291K | Buy |
3,120
+965
| +45% | +$90K | ﹤0.01% | 3226 |
|
|
2015
Q4 | $437K | Buy |
+2,155
| New | +$437K | ﹤0.01% | 3262 |
|